Journal articles on the topic 'Insulin'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Insulin.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Hansenne, Isabelle Sylvie, Chantal Renard, and Vincent Geenen. "Igf2 expression is required for complete tolerance to insulin (128.19)." Journal of Immunology 178, no. 1_Supplement (2007): S213—S214. http://dx.doi.org/10.4049/jimmunol.178.supp.128.19.
Full textShestakova, Marina Vladimirovna, and Irina Vladimirovna Glinkina. "Insulin glargine does not increase the risk of malignancy.Synopsis of the article ?Combined randomised controlled trial experience of malignancies in studies using insulin glargine?byHome P.D. & Lagarenne P. (Diabetologia 2009, vol. 52 (12): 2499-2506)." Diabetes mellitus 13, no. 1 (2010): 88–90. http://dx.doi.org/10.14341/2072-0351-6022.
Full textDąbrowski, Mariusz. "U kogo i dlaczego warto zastosować insulinę dwuanalogową aspart + degludec?" Medycyna Faktów 16, no. 2(59) (2023): 227–33. http://dx.doi.org/10.24292/01.mf.0223.15.
Full textModi, K. D., Pradeep V. Gadge, Pradeep Jain, et al. "Clinical challenges with excipients in insulin formulations and role of concentrated insulin." International Journal of Basic & Clinical Pharmacology 8, no. 4 (2019): 821. http://dx.doi.org/10.18203/2319-2003.ijbcp20191125.
Full textKucera, Michelle L., and John P. Graham. "Insulin Lispro, a New Insulin Analog." Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 18, no. 3 (1998): 526–38. http://dx.doi.org/10.1002/j.1875-9114.1998.tb03116.x.
Full textRay, Sumit. "Insulin infusion protocol (Human insulin®/Insugen®)." Current Medicine Research and Practice 4, no. 4 (2014): 186–87. http://dx.doi.org/10.1016/j.cmrp.2014.08.007.
Full textGargiulo, P., U. Di Mario, O. Zuccarini, et al. "Treatment of diabetic pregnant women with monocomponent insulins." Acta Endocrinologica 113, no. 3_Suppl (1986): S60—S65. http://dx.doi.org/10.1530/acta.0.111s0060.
Full textMbanya, Jean Claude, Juergen Sandow, Wolfgang Landgraf, and David R. Owens. "Recombinant Human Insulin in Global Diabetes Management – Focus on Clinical Efficacy." European Endocrinology 13, no. 01 (2017): 21. http://dx.doi.org/10.17925/ee.2017.13.01.21.
Full textAhmed Aziz, Kamran Mahmood. "Role of New Insulin Analogs in the Management of Diabetes. A Clinical Review." Diabetes & Obesity International Journal 8, no. 1 (2023): 1–8. http://dx.doi.org/10.23880/doij-16000269.
Full textHirsch, Irl B., Rattan Juneja, John M. Beals, Caryl J. Antalis, and Eugene E. Wright. "The Evolution of Insulin and How it Informs Therapy and Treatment Choices." Endocrine Reviews 41, no. 5 (2020): 733–55. http://dx.doi.org/10.1210/endrev/bnaa015.
Full textZHANG, Zhou. "Protein engineering of insulin: Two novel fast-acting insulins [B16Ala]insulin and [B26Ala]insulin." Science in China Series C 46, no. 5 (2003): 474. http://dx.doi.org/10.1360/01yc0295.
Full textHarned, Leighton Kahle, and Edward Chin. "PSUN278 Factitious hypoglycemia, diagnostic delay due to insulin assay failure to detect insulin analogues." Journal of the Endocrine Society 6, Supplement_1 (2022): A403. http://dx.doi.org/10.1210/jendso/bvac150.838.
Full textDzhavakhishvili, T. S., T. I. Romantsova, and O. V. Roik. "Influence of the dynamics of body weight on the risk factors of cardiovascular disease in patients with type 2 diabetes during the first year of insulin treatment." Obesity and metabolism 10, no. 1 (2013): 22–25. http://dx.doi.org/10.14341/2071-8713-5067.
Full textHale, Genevieve, Valerie Marcellus, Tina Benny, Cynthia Moreau, Elaina Rosario, and Alexandra Perez. "Real-World Analysis of Long-Acting and NPH-Containing Insulins on Glycemic Control." Senior Care Pharmacist 39, no. 1 (2024): 42–49. http://dx.doi.org/10.4140/tcp.n.2024.42.
Full textPatel, Supriya. "Biosimilar insulins in diabetes management: A cost-effective shift in therapeutic options." Innovations in Pharmacy Planet 12, no. 01 (2024): 16–19. https://doi.org/10.31690/ipplanet.2024.v012i01.005.
Full textJermendy, György. "Intensive conservative insulin treatment in patients with type 2 diabetes mellitus." Orvosi Hetilap 153, no. 38 (2012): 1487–93. http://dx.doi.org/10.1556/oh.2012.29451.
Full textDemidova, Tatiana Y., and Olga V. Balutina. "Special aspects of concentrated insulins: basic characteristics and research findings." Diabetes mellitus 22, no. 5 (2020): 481–90. http://dx.doi.org/10.14341/dm10334.
Full textBroussard, John D., and Mark E. Peterson. "Comparison of two ultralente insulin preparations with protamine zinc insulin in clinically normal cats." American Journal of Veterinary Research 55, no. 1 (1994): 127–31. http://dx.doi.org/10.2460/ajvr.1994.55.01.127.
Full textPeterson, Gregory E. "Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir." Current Medical Research and Opinion 22, no. 12 (2006): 2613–19. http://dx.doi.org/10.1185/030079906x154178.
Full textDanne, Thomas, and Jan Bolinder. "New Insulins and Insulin Therapy." Diabetes Technology & Therapeutics 15, S1 (2013): S—40—S—47. http://dx.doi.org/10.1089/dia.2013.1505.
Full textDanne, Thomas, and Jan Bolinder. "New Insulins and Insulin Therapy." Diabetes Technology & Therapeutics 16, S1 (2014): S—34—S—43. http://dx.doi.org/10.1089/dia.2014.1505.
Full textBolinder, Jan, and Thomas Danne. "New Insulins and Insulin Therapy." Diabetes Technology & Therapeutics 17, S1 (2015): S—39—S—46. http://dx.doi.org/10.1089/dia.2015.1505.
Full textDanne, T., and J. Bolinder. "New insulins and insulin therapy." International Journal of Clinical Practice 65 (February 2011): 26–30. http://dx.doi.org/10.1111/j.1742-1241.2010.02576.x.
Full textDanne, Thomas, and Jan Bolinder. "New insulins and insulin therapy." International Journal of Clinical Practice 66 (February 2012): 30–34. http://dx.doi.org/10.1111/j.1742-1241.2011.02851.x.
Full textMao, Xuhua, Hucheng Chen, Junmin Tang, Liangliang Wang, and Tingting Shu. "Hepcidin links gluco-toxicity to pancreatic beta cell dysfunction by inhibiting Pdx-1 expression." Endocrine Connections 6, no. 3 (2017): 121–28. http://dx.doi.org/10.1530/ec-16-0115.
Full textPetrukhin, Aleksey. "Pump Insulin Therapy and Continuous Glycemic Monitoring." Spravočnik vrača obŝej praktiki (Journal of Family Medicine), no. 6 (June 1, 2020): 26–32. http://dx.doi.org/10.33920/med-10-2006-03.
Full textDzhavakhishvili, T. Sh, T. I. Romantsova, and O. V. Roik. "Dinamika massy tela u bol'nykh sakharnymdiabetom 2 tipa v techenie pervogo godainsulinoterapii." Obesity and metabolism 7, no. 4 (2010): 13–19. http://dx.doi.org/10.14341/2071-8713-5082.
Full textSandow, Juergen, Wolfgang Landgraf, Reinhard Becker, and Gerhard Seipke. "Equivalent Recombinant Human Insulin Preparations and their Place in Therapy." European Endocrinology 11, no. 1 (2015): 10. http://dx.doi.org/10.17925/ee.2015.11.01.10.
Full textRosenstock, Julio, Harpreet S. Bajaj, Ildiko Lingvay, and Simon R. Heller. "Clinical perspectives on the frequency of hypoglycemia in treat-to-target randomized controlled trials comparing basal insulin analogs in type 2 diabetes: a narrative review." BMJ Open Diabetes Research & Care 12, no. 3 (2024): e003930. http://dx.doi.org/10.1136/bmjdrc-2023-003930.
Full textDiaz, J. L., and T. J. Wilkin. "Effect of iodination site on binding of radiolabeled ligand by insulin antibodies and insulin autoantibodies." Clinical Chemistry 34, no. 2 (1988): 356–59. http://dx.doi.org/10.1093/clinchem/34.2.356.
Full textXu, Juan, Shanshan Zhang, Guohui Zhang, Lihua Huang, and Qinghua Yi. "Research Progress on the Efficacy and Safety of Different Basal Insulins in the Treatment of Type 2 Diabetes Mellitus." Journal of Clinical and Nursing Research 8, no. 6 (2024): 21–25. http://dx.doi.org/10.26689/jcnr.v8i6.7670.
Full textRasmussen, Jack T., and Heather J. Ipema. "Formulary Considerations for Insulins Approved Through the 505(b)(2) “Follow-on” Pathway." Annals of Pharmacotherapy 53, no. 2 (2018): 204–10. http://dx.doi.org/10.1177/1060028018795834.
Full textKumar, Sinha Ritesh, and Chandra Satish. "Insulin resistance." Asian Pacific Journal of Health Sciences, Supplimentary 2014 (2014): 71–78. http://dx.doi.org/10.21276/apjhs.2014.1.1s.15.
Full textBansal, Naresh, Narendra Kotwal, Anuj Singhal, and Ashish Kumar. "Insulin: The Journey Continues." Journal of Marine Medical Society 26, no. 1 (2023): 3–8. http://dx.doi.org/10.4103/jmms.jmms_90_23.
Full textAndrade, Pedro, Luísa Barros, and Margarida Gonçalo. "Type 1 Ig-E mediated allergy to human insulin, insulin analogues and beta-lactam antibiotics." Anais Brasileiros de Dermatologia 87, no. 6 (2012): 917–19. http://dx.doi.org/10.1590/s0365-05962012000600018.
Full textThomas, J. W., V. J. Virta, and L. J. Nell. "Heterogeneity and specificity of human anti-insulin antibodies determined by isoelectric focusing." Journal of Immunology 134, no. 2 (1985): 1048–52. http://dx.doi.org/10.4049/jimmunol.134.2.1048.
Full textDuan, C., T. Noso, S. Moriyama, H. Kawauchi, and T. Hirano. "Eel insulin: isolation, characterization and stimulatory actions on [35S]sulphate and [3H]thymidine uptake in the branchial cartilage of the eel in vitro." Journal of Endocrinology 133, no. 2 (1992): 221–30. http://dx.doi.org/10.1677/joe.0.1330221.
Full textNdayishimye, Samuel *. Prudence A. Rodrigues. "HUMAN INSULIN AND INSULIN ANALOGUES IN MANAGEMENT OF DIABETES MELLITUS." Journal of Pharma Research 7, no. 10 (2018): 224–26. https://doi.org/10.5281/zenodo.1468476.
Full textBajaj, M., T. L. Blundell, R. Horuk, et al. "Coypu insulin. Primary structure, conformation and biological properties of a hystricomorph rodent insulin." Biochemical Journal 238, no. 2 (1986): 345–51. http://dx.doi.org/10.1042/bj2380345.
Full textSkowronek, Rafał, Ewa Zielińska-Pająk, and Piotr Paleń. "Immunohistochemical detection of insulin at the injection site in a case of suspected murder with the suicide of the perpetrator." Archives of Forensic Medicine and Criminology 72, no. 3 (2023): 147–50. http://dx.doi.org/10.4467/16891716amsik.22.017.17395.
Full textJayagopal, Vijay, Russell Drummond, and Dinesh Nagi. "Association of British Clinical Diabetologists (ABCD) position statement on the use of biosimilar insulin." British Journal of Diabetes 18, no. 4 (2018): 171–74. http://dx.doi.org/10.15277/bjd.2018.190.
Full textGotham, Dzintars, Melissa J. Barber, and Andrew Hill. "Production costs and potential prices for biosimilars of human insulin and insulin analogues." BMJ Global Health 3, no. 5 (2018): e000850. http://dx.doi.org/10.1136/bmjgh-2018-000850.
Full textDedov, I. I., and M. V. Shestakova. "On the centenary of the insulin discovery." Diabetes mellitus 24, no. 1 (2021): 11–16. http://dx.doi.org/10.14341/dm12733.
Full text&NA;. "Insulin analogues show promise as short-acting insulins in insulin-dependent diabetes." Inpharma Weekly &NA;, no. 798 (1991): 17. http://dx.doi.org/10.2165/00128413-199107980-00045.
Full textTaylor, M. Joan, Krishan P. Chauhan, and Tarsem S. Sahota. "Glucose lowering strategies with insulin." British Journal of Diabetes 19, no. 2 (2019): 124–30. http://dx.doi.org/10.15277/bjd.2019.228.
Full textFerencz, Viktória, Beatrix Domján, László Gerő, Tímea Tänczer, and Gy Ádám Tabák. "A normoglykaemia elérésének korlátai inzulinkezelt 2-es típusú cukorbetegekben." Orvosi Hetilap 156, no. 36 (2015): 1443–50. http://dx.doi.org/10.1556/650.2015.30239.
Full textEwen, Margaret, Huibert-Jan Joosse, David Beran, and Richard Laing. "Insulin prices, availability and affordability in 13 low-income and middle-income countries." BMJ Global Health 4, no. 3 (2019): e001410. http://dx.doi.org/10.1136/bmjgh-2019-001410.
Full textAndrianova, E. A. "The use of ultra-short acting insulin preparations for insulin pumps." Problems of Endocrinology 58, no. 3 (2012): 46–50. http://dx.doi.org/10.14341/probl201258346-50.
Full text&NA;. "Insulin/insulin aspart/insulin glargine." Reactions Weekly &NA;, no. 1338 (2011): 24. http://dx.doi.org/10.2165/00128415-201113380-00077.
Full textDanne, Thomas, Lutz Heinemann, and Jan Bolinder. "New Insulins, Biosimilars, and Insulin Therapy." Diabetes Technology & Therapeutics 23, S2 (2021): S—46—S—68. http://dx.doi.org/10.1089/dia.2021.2504.
Full text